New evidence is presented on how specialised nutrition can improve lean body mass, clinical outcomes, and healthcare costs in ageing and illness. In a large, prospective, randomized, interventional, double-blind placebo-controlled trial (The ‘NOURISH’ Study†
), high protein (HP) oral nutritional supplementation (ONS) containing β-hydroxy β-methylbutyrate (HMB), or HP-HMB, in malnourished, hospitalized older adults was associated with improved nutritional status and decreased post-discharge mortality. A health economic evaluation of The NOURISH Study shows that HP-HMB is cost-effective and extends the lives of malnourished hospitalized patients.
†NOURISH = Nutrition effect On Unplanned ReadmIssions and Survival in Hospitalized patients